Stocks
ANI Pharmaceuticals (ANIP) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 60.8 | 28.6 | 14.7 | 31.9 | 109.3 | 104.4 | ||
| Changes by years, y/y, % | -11% | -53% | -48% | +116% | +243% | +9.8% | |||
ANI Pharmaceuticals. EBITDA US GAAP, bln rub
ANI Pharmaceuticals. EBITDA US GAAP, changes, %
ANI Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
ANI Pharmaceuticals (ANIP) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 28.1 | 30.6 | 23.9 | 29.7 | 20.2 | 104.4 | |
| Changes by years, y/y, % | +777% | +112% | +23% | +12% | -28% | |||
| Changes by quarters, q/q, % | +5% | +9% | -22% | +24% | -32% | |||
